PharmaLenz

"Our goal is to enable faster and more accurate antibody discovery by leveraging AI to predict drug-like properties before laboratory validation, addressing the industry's biggest challenges in targeting undruggable diseases."

"We're building a leading ADC powerhouse with our proprietary ADCX-Engine, focusing on novel payloads and linker architectures to overcome resistance and transform cancer therapy for patients with high unmet needs."

"By targeting transcription factors—the master controllers of gene expression—we aim to reprogram diseased cells into healthy states, developing true disease-modifying therapies for neurodegeneration."

"Our explainable AI approach models protein grammar to discover novel therapeutics with improved manufacturability and efficacy, bridging the gap between computational predictions and real-world drug development."